Suppr超能文献

相似文献

1
The genetic spectrum of human neuronal ceroid-lipofuscinoses.
Brain Pathol. 2004 Jan;14(1):70-6. doi: 10.1111/j.1750-3639.2004.tb00500.x.
2
Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.
Neurogenetics. 2005 Sep;6(3):107-26. doi: 10.1007/s10048-005-0218-3. Epub 2005 Sep 28.
4
Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
Hum Mutat. 1999;14(3):199-215. doi: 10.1002/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A.
5
The molecular genetic basis of the neuronal ceroid lipofuscinoses.
Neurol Sci. 2000;21(3 Suppl):S15-9. doi: 10.1007/s100720070035.
6
Biochemistry of neuronal ceroid lipofuscinoses.
Adv Genet. 2001;45:93-106. doi: 10.1016/s0065-2660(01)45005-x.
8
Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
Genet Med. 2000 Nov-Dec;2(6):312-8. doi: 10.1097/00125817-200011000-00002.
9
Neuronal ceroid lipofuscinoses: research update.
Neurol Sci. 2000;21(3 Suppl):S49-56. doi: 10.1007/s100720070040.
10
Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
Adv Genet. 2001;45:35-68. doi: 10.1016/s0065-2660(01)45003-6.

引用本文的文献

1
Case Report: The window that closed too soon: lessons from a late CLN2 diagnosis and death of a 9-year-old boy.
Front Genet. 2025 Jul 4;16:1622185. doi: 10.3389/fgene.2025.1622185. eCollection 2025.
2
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease.
bioRxiv. 2025 May 31:2025.05.30.656864. doi: 10.1101/2025.05.30.656864.
3
Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease.
Ophthalmol Sci. 2024 May 29;4(6):100560. doi: 10.1016/j.xops.2024.100560. eCollection 2024 Nov-Dec.
4
Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa.
Front Neurol. 2025 Mar 14;16:1516026. doi: 10.3389/fneur.2025.1516026. eCollection 2025.
6
Frameshift Variant in in Cirneco dell'Etna Dogs with Retinopathy and Tremors.
Genes (Basel). 2024 Feb 13;15(2):238. doi: 10.3390/genes15020238.
7
The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis.
Neurobiol Dis. 2023 Sep;185:106258. doi: 10.1016/j.nbd.2023.106258. Epub 2023 Aug 11.
9
Phenotypic Variability of Retinal Disease Among a Cohort of Patients With Variants in the CLN Genes.
Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):23. doi: 10.1167/iovs.64.3.23.
10
The LINCE Project: A Pathway for Diagnosing NCL2 Disease.
Front Pediatr. 2022 Mar 29;10:876688. doi: 10.3389/fped.2022.876688. eCollection 2022.

本文引用的文献

3
Disruption of PPT2 in mice causes an unusual lysosomal storage disorder with neurovisceral features.
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12325-30. doi: 10.1073/pnas.2033229100. Epub 2003 Oct 3.
4
Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis.
Hum Mutat. 2003 Jul;22(1):35-42. doi: 10.1002/humu.10227.
5
Membrane topology of CLN3, the protein underlying Batten disease.
FEBS Lett. 2003 Apr 24;541(1-3):40-6. doi: 10.1016/s0014-5793(03)00284-9.
7
Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
J Biol Chem. 2003 Feb 28;278(9):7135-45. doi: 10.1074/jbc.M211872200. Epub 2002 Dec 17.
8
Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles.
J Med Genet. 2002 Nov;39(11):822-5. doi: 10.1136/jmg.39.11.822.
9
A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis.
J Neurol. 2002 Oct;249(10):1398-400. doi: 10.1007/s00415-002-0849-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验